At the time of writing, Agios Pharmaceuticals Inc [AGIO] stock is trading at $35.22, up 4.36%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The AGIO shares have gain 5.77% over the last week, with a monthly amount glided 3.41%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On September 27, 2024, downgrade downgraded it’s rating to Market Perform and revised its price target to $56 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating. Piper Sandler initiated its recommendation with a Overweight and recommended $41 as its price target on February 03, 2023. Goldman upgraded its rating to Neutral for this stock on November 17, 2022, and upped its price target to $32. In a note dated July 27, 2022, SVB Leerink upgraded an Outperform rating on this stock but restated the target price of $33.
For the past year, the stock price of Agios Pharmaceuticals Inc fluctuated between $26.50 and $62.58. Currently, Wall Street analysts expect the stock to reach $53.5 within the next 12 months. Agios Pharmaceuticals Inc [NASDAQ: AGIO] shares were valued at $35.22 at the most recent close of the market. An investor can expect a potential return of 51.9% based on the average AGIO price forecast.
Analyzing the AGIO fundamentals
According to Agios Pharmaceuticals Inc [NASDAQ:AGIO], the company’s sales were 36.50M for trailing twelve months, which represents an 51.06% jump. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at -11.66%, Pretax Profit Margin comes in at 19.67%, and Net Profit Margin reading is 18.46%. To continue investigating profitability, this company’s Return on Assets is posted at 0.41, Equity is 0.59 and Total Capital is -0.27. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 34.21 points at the first support level, and at 33.21 for the second support level. However, for the 1st resistance point, the stock is sitting at 35.76, and for the 2nd resistance point, it is at 36.31.
Ratios To Look Out For
It is important to note that Agios Pharmaceuticals Inc [NASDAQ:AGIO] has a current ratio of 11.90. Further, the Quick Ratio stands at 11.56, while the Cash Ratio is 0.94. Considering the valuation of this stock, the price to sales ratio is 55.29, the price to book ratio is 1.31 and price to earnings (TTM) ratio is 3.09.
Transactions by insiders
Recent insider trading involved Washburn Theodore James Jr., Principal Accounting Officer, that happened on Feb 05 ’25 when 2272.0 shares were sold. Chief Commercial Officer, Milanova Tsveta completed a deal on Jan 06 ’25 to sell 2804.0 shares. Meanwhile, Officer Milanova Tsveta bought 2804.0 shares on Jan 03 ’25.
